The purpose of the study is to investigate a treatment drug, idalopirdine, for Alzheimer's disease.
You may be eligible to participate if you:
- Are at least 50 years of age
- Have a BMI of >18 kg/m2
- Currently take donezepil
The study involves three overnight stays, one screening/MRI visit, up to three onsite PET scan visits, and one follow-up visit. You may be compensated up to $4,600 for time and travel.
To find out more about this opportunity to participate in clinical research, please contact the lab at 410-955-1256 or firstname.lastname@example.org.
Study number: IRB 00138207
Principal investigator: Dean F. Wong, MD, PhD